Your session is about to expire
← Back to Search
Ciclopirox Olamine Oral for Side Effects
Study Summary
This trial tests a drug's safety, how it affects the body, and how it is absorbed in healthy people.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does this medical intervention have regulatory authorization?
"A rating of '1' was assigned to this intervention because it is currently in the first phase, which implies that there is minimal data demonstrating its safety and efficacy."
Does this research encompass applicants aged 18 and older?
"This experiment is open to all adults aged 18-65."
What is the current enrollment figure for this research endeavor?
"Affirmative. According to clinicaltrials.gov, the trial was first published on March 27th 2023 and is now seeking 32 patients from a single location."
Are new patient enrollees welcomed into this experiment at the moment?
"According to clinicaltrials.gov, the trial is actively seeking out participants; it was initially posted on March 27th 2023 and underwent a recent update on March 28th of the same year."
To whom is enrollment to this trial open?
"The study is seeking 32 individuals aged 18-65 affected by side effects, who possess a BMI between 18.0 and 33.0 kg/m2 inclusive, along with at least 50.0kg of body weight to the highest maximum of 100.0kg as measured in screening tests."
Share this study with friends
Copy Link
Messenger